Exhibitors & Sponsors - HSES

Exhibitors and Sponsors

*For pharma and life sciences companies, attendance is exclusively available through sponsorship.*

INQUIRE ABOUT SPONSORSHIP VIEW SPEAKERS SEE AGENDA

Exhibitors & Sponsors - HSES

Why Sponsor

Attendance access

For pharmaceutical industry members, attendance is exclusively available through sponsorship. Your investment directly secures your seat at the table.

Thought leadership platform

Present alongside faculty, contribute to working sessions and shape the conversation on biosimilars, 340B, IRA policy and value-based care.

Managed Healthcare Executive^® (MHE) brand reach

Insights from the summit are published through MHE to reach a national audience of managed care professionals.

A decision-forward audience mix

Connect with senior health system leadership — the decision-makers navigating the most complex clinical, financial and operational challenges in healthcare today.

Relationship-first format

The summit’s intimate working-forum structure encourages in-depth dialogue — not badge scans. Build relationships that outlast the event.

Who Attends

Represented systems include: University of California (UC) San Francisco, UC Davis, AON, Providence, Sutter, Stanford, Adventist, and more.

Health system executives

Senior leaders including CEOs, COOs and CFOs responsible for system-wide strategy and operations.

Pharmacy and drug strategy

CPOs, pharmacy directors and leaders managing formulary, contracting and specialty pharmacy.

Policy and regulatory executives

Executives navigating Medicaid/Medicare policy shifts, IRA implications and healthcare legislation.

Clinical leadership

CMOs, CNOs and physician leaders overseeing care delivery, quality and clinical programs.

Population health and VBC leaders

Leaders driving value-based care models, risk strategy and outcomes-focused program design.

Finance and operations

CFOs, VPs of finance, and operational leaders managing cost, margin and infrastructure strategy.

Agenda Themes

Exhibitors & Sponsors - HSES

Medicare & Medicaid policy shifts and IDN impact
IRA implications for drug costs and biosimilars
340B sustainability and operational strategy
AI and digital tools in clinical and operational decision-making

Immunization and population health system approaches
Health system-owned vs payer-owned specialty pharmacy models
Financial sustainability in modern healthcare delivery
Evidence-based clinical protocols and nationwide knowledge sharing

Sponsorship Opportunities

All tiers include conference passes, logo recognition in signage and a print ad in MHE. Higher tiers unlock exhibit space, seat drops, MHE publication pages and exclusive activations. Contact us for pricing.